B
Biora Therapeutics
Clinical laboratory services to provide physicians and patients with accurate, timely and state-of-the-art test results
About Biora Therapeutics
Biora Therapeutics is a biotechnology company focused on revolutionizing the delivery of therapeutics. The company specializes in developing innovative smart pill technologies designed for targeted drug delivery to the gastrointestinal (GI) tract and systemic, needle-free delivery of large molecules. These advancements aim to replace traditional injection methods, offering a more convenient and less invasive option for patients managing chronic diseases. Biora Therapeutics serves a diverse range of clients, including healthcare providers, pharmaceutical companies, and patients seeking advanced therapeutic solutions. Operating in the biopharmaceutical market, the company leverages its proprietary technologies, such as NaviCap, BioJet, and GITrac, to create value. Biora's business model involves the development and commercialization of these smart pill technologies, generating revenue through product sales, licensing agreements, and potential partnerships with larger pharmaceutical firms. The company is currently in the investigational stage, with its products limited to investigational use by Federal law.
Source: Dealroom company dataAt a glance
- Founded
- 2010
- Headquarters
- San Diego, United States
- Listing
- IPO 2020
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Biora Therapeutics.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Athyrium Capital Management
Series B and later2 investors entered at this stage
- HMHighbridge Capital Management
Davidson Kempner Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
44 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biora Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biora Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.